US Broker Ratings

Twist Bioscience Corporation (TWST) Stock Analysis: Unpacking a 10.29% Potential Upside in the Diagnostics & Research Sector

Twist Bioscience Corporation (NASDAQ: TWST), a key player in the healthcare sector’s diagnostics and research industry, presents an intriguing opportunity for investors with its impressive array of synthetic DNA-based products...

ImmunityBio, Inc. (IBRX) Investor Outlook: Unpacking the 400% Potential Upside

ImmunityBio, Inc. (NASDAQ: IBRX), a promising player in the biotechnology sector, has been making waves with its ambitious approach to harnessing the body’s immune system to fight cancer and infectious..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Unlocking a 24% Potential Upside in the CNS Market

Investors eyeing the healthcare sector may find Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) to be a compelling opportunity, particularly given its strategic focus on central nervous system (CNS) disorders. With a..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: A Healthcare Innovator with 16% Upside Potential

Alphatec Holdings, Inc. (ATEC), a key player in the medical devices sector, is capturing investor attention with its cutting-edge innovations in spinal disorder treatments. Headquartered in Carlsbad, California, Alphatec is..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Strong Buy Ratings Signal 21% Potential Upside

LifeStance Health Group, Inc. (NASDAQ: LFST), a prominent player in the U.S. healthcare sector, is capturing investor attention with its robust growth prospects and dominant position in the outpatient mental..

Metsera, Inc. (MTSR) Stock Analysis: Navigating a 19% Downside in Biotech’s Promising Frontier

Metsera, Inc. (MTSR), a clinical-stage biotechnology company based in New York, is at the forefront of developing innovative therapies targeting obesity and related disorders. Despite its potential, current market valuations..

Privia Health Group, Inc. (PRVA) Stock Analysis: Riding a 29.51% Potential Upside Wave

Privia Health Group, Inc. (NASDAQ: PRVA) is making waves in the healthcare sector with its innovative approach to physician enablement and value-based care. As a national player in the health..

Alvotech (ALVO) Stock Analysis: Unveiling a Striking 352% Potential Upside

Alvotech (ALVO), a prominent player in the healthcare sector specializing in biosimilar medicines, is capturing the attention of investors with its staggering potential upside. Based in Luxembourg, Alvotech operates in..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A 36.45% Potential Upside Captivates Investors

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) has been catching the eye of investors, particularly with the enticing potential upside of 36.45%, as indicated by analysts’ average target price. This biopharmaceutical company,..

Denali Therapeutics Inc. (DNLI) Stock Analysis: A Biotech Powerhouse with 101% Upside Potential

Denali Therapeutics Inc. (NASDAQ: DNLI) is making waves in the biotechnology sector with its ambitious pipeline targeting some of the most challenging neurodegenerative and lysosomal storage diseases. With a market..

Zai Lab Limited (ZLAB): Investor Outlook on a Biotech Powerhouse with a Promising 171% Upside

Investors keeping an eye on the biotechnology sector should not overlook Zai Lab Limited (NASDAQ: ZLAB), a prominent player in the healthcare industry. With a market capitalization of $2 billion,..

Organon & Co. (OGN) Stock Analysis: Exploring the 25.77% Potential Upside for Investors

Investors on the lookout for opportunities in the healthcare sector may find Organon & Co. (NYSE: OGN) an intriguing prospect. With a market capitalization of $1.93 billion, this company is..

Crinetics Pharmaceuticals (CRNX) Stock Analysis: A Deep Dive into 71% Upside Potential

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is capturing investor attention with its significant upside potential, evident in the latest analyst ratings that suggest a possible 71.08% increase from its current stock..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: Navigating a 40.73% Potential Upside in the Biotech Space

Apellis Pharmaceuticals, Inc. (APLS), a prominent player in the biotechnology industry, continues to capture investor attention with its strategic focus on novel therapeutic compounds. Based in Waltham, Massachusetts, Apellis is..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a Potential 48.20% Upside with a High Dividend Yield

Perrigo Company plc (NASDAQ: PRGO) stands as a significant player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Dublin, Ireland, Perrigo’s extensive portfolio..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating Challenges with a Promising Dividend Yield

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, specializing in medical instruments and supplies, is currently attracting attention with its compelling dividend yield amidst a challenging..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 65.94% Upside Potential Amid Sector Growth

Surgery Partners, Inc. (NASDAQ: SGRY) has emerged as an intriguing proposition for investors eyeing the healthcare sector. With its strategic focus on surgical facilities and ancillary services, the company has..

Viking Therapeutics, Inc. (VKTX): Biotech Stock with a 190% Upside Potential – An Investor’s Insight

Viking Therapeutics, Inc. (NASDAQ: VKTX) has been capturing the attention of investors in the biotech sector, thanks to its ambitious drug development pipeline and the potential for significant stock appreciation...

LivaNova PLC (LIVN) Stock Analysis: Exploring a Potential 11.71% Upside in Medical Devices

As the healthcare sector continues to play a pivotal role in global economies, LivaNova PLC (NASDAQ: LIVN) stands out as a noteworthy player in the medical devices industry. Headquartered in..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Opportunities in the Dental Industry

Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector, is capturing investor interest with its focus on dental products. Operating primarily within the medical instruments and supplies..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds